CARDIOVASCULAR OUTCOMES WITH β-BLOCKER COMBINATION TREATMENT IN PATIENTS WITH HYPERTENSION: A LARGE, RETROSPECTIVE COHORT STUDY

CARDIOVASCULAR OUTCOMES WITH β-BLOCKER COMBINATION TREATMENT IN PATIENTS WITH HYPERTENSION: A LARGE, RETROSPECTIVE COHORT STUDY

First BB claim on/after 1/1/2008 defined index drug and date. The primary outcome was hospitalization risk for composite CV outcome (MI, CHF, stroke, angina) assessed by Cox proportional hazards regression of time to event, adjusted for concomitant anti-HTN medication possession ratios (>=75%) an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A1752
Hauptverfasser: Egan, Brent, Basile, Jan, Punzi, Henry, Sanjida Ali, Li, Qian, Patel, Mehul, Neutel, Joel
Format: Artikel
Sprache:eng
Schlagworte:
Angina pectoris
Beta blockers
Cardiology
Cohort analysis
Health risk assessment
Hospitalization
Hypertension
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:First BB claim on/after 1/1/2008 defined index drug and date. The primary outcome was hospitalization risk for composite CV outcome (MI, CHF, stroke, angina) assessed by Cox proportional hazards regression of time to event, adjusted for concomitant anti-HTN medication possession ratios (>=75%) and baseline confounders balanced in matching.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)32293-9